A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates

por Pino, Maria, Abid, Talha, Pereira Ribeiro, Susan, Edara, Venkata Viswanadh, Floyd, Katharine, Smith, Justin C., Latif, Muhammad Bilal, Pacheco-Sanchez, Gabriela, Dutta, Debashis, Wang, Shelly, Gumber, Sanjeev, Kirejczyk, Shannon, Cohen, Joyce, Stammen, Rachelle L., Jean, Sherrie M., Wood, Jennifer S., Connor-Stroud, Fawn, Pollet, Jeroen, Chen, Wen-Hsiang, Wei, Junfei, Zhan, Bin, Lee, Jungsoon, Liu, Zhuyun, Strych, Ulrich, Shenvi, Neeta, Easley, Kirk, Weiskopf, Daniela, Sette, Alessandro, Pollara, Justin, Mielke, Dieter, Gao, Hongmei, Eisel, Nathan, LeBranche, Celia C., Shen, Xiaoying, Ferrari, Guido, Tomaras, Georgia D., Montefiori, David C., Sekaly, Rafick P., Vanderford, Thomas H., Tomai, Mark A., Fox, Christopher B., Suthar, Mehul S., Kozlowski, Pamela A., Hotez, Peter J., Paiardini, Mirko, Bottazzi, Maria Elena, Kasturi, Sudhir Pai
Publicado 2021